Real-world experience with the pentaspline pulsed field ablation system: one-year outcomes of the FARADISE registry
Lucas V.A. Boersma(St. Antonius Ziekenhuis), Johan Vijgen(Jessa Hospital), Armin Luik(Städtisches Klinikum Karlsruhe), Martin Fiala(University Hospital Brno), Estelle Gandjbakhch(Sorbonne Université), Haris M. Haqqani(The University of Queensland), Ignacio García‐Bolao(Clinica Universidad de Navarra), N Cielen(Boston Scientific (United States)), Joaquín Osca(Hospital Universitari i Politècnic La Fe), Michael Efremidis(Onassis Cardiac Surgery Center), Francesco Solimene(Marche Polytechnic University), Sélim Abbey(Hôpital privé du Confluent), Nándor Szegedi(Semmelweis University), Patrick Lugenbiel(Heidelberg University), Stephan Willems(Atrial Fibrillation NETwork), Pascal Defaye(Universitat Autònoma de Barcelona), Antonio Dello Russo(Texas Cardiac Arrhythmia), Madeline Johnson(Boston Scientific (United States)), Gábor Széplaki(Royal College of Surgeons in Ireland), Brad Sutton(Boston Scientific (United States)), Azlan Hussin(National Heart Institute), George Andrikopoulos(Henry Dunant Hospital), J. Herzet(Centre hospitalier régional de la Citadelle), Elizabeth M. Albrecht(Boston Scientific (United States)), Lars Eckardt(Klinik und Poliklinik für Psychosomatik und Psychotherapie), Javier Ramos Maqueda(Hospital Clínico Universitario Lozano Blesa), Alexandre Ouss(Radboud University Nijmegen)
Cited by 17
Related Papers
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device
|Circulation|2016|855
Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure
|New England Journal of Medicine|2008|763
Left Atrial Appendage
|Circulation|2010|633